210 related articles for article (PubMed ID: 11375394)
1. Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae beta-ketoacyl-acyl carrier protein synthase III (FabH).
Khandekar SS; Gentry DR; Van Aller GS; Warren P; Xiang H; Silverman C; Doyle ML; Chambers PA; Konstantinidis AK; Brandt M; Daines RA; Lonsdale JT
J Biol Chem; 2001 Aug; 276(32):30024-30. PubMed ID: 11375394
[TBL] [Abstract][Full Text] [Related]
2. Purification, characterization, and identification of novel inhibitors of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
He X; Reynolds KA
Antimicrob Agents Chemother; 2002 May; 46(5):1310-8. PubMed ID: 11959561
[TBL] [Abstract][Full Text] [Related]
3. Characterization of beta-ketoacyl-acyl carrier protein synthase III from Streptomyces glaucescens and its role in initiation of fatty acid biosynthesis.
Han L; Lobo S; Reynolds KA
J Bacteriol; 1998 Sep; 180(17):4481-6. PubMed ID: 9721286
[TBL] [Abstract][Full Text] [Related]
4. Development of a scintillation proximity assay for beta-ketoacyl-acyl carrier protein synthase III.
He X; Mueller JP; Reynolds KA
Anal Biochem; 2000 Jun; 282(1):107-14. PubMed ID: 10860506
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli.
Heath RJ; Rock CO
J Biol Chem; 1996 May; 271(18):10996-1000. PubMed ID: 8631920
[TBL] [Abstract][Full Text] [Related]
6. The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII.
Prigge ST; He X; Gerena L; Waters NC; Reynolds KA
Biochemistry; 2003 Feb; 42(4):1160-9. PubMed ID: 12549938
[TBL] [Abstract][Full Text] [Related]
7. Enzymes involved in fatty acid and polyketide biosynthesis in Streptomyces glaucescens: role of FabH and FabD and their acyl carrier protein specificity.
Florova G; Kazanina G; Reynolds KA
Biochemistry; 2002 Aug; 41(33):10462-71. PubMed ID: 12173933
[TBL] [Abstract][Full Text] [Related]
8. Identification and substrate specificity of beta -ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis.
Choi KH; Kremer L; Besra GS; Rock CO
J Biol Chem; 2000 Sep; 275(36):28201-7. PubMed ID: 10840036
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure and substrate specificity of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
Qiu X; Choudhry AE; Janson CA; Grooms M; Daines RA; Lonsdale JT; Khandekar SS
Protein Sci; 2005 Aug; 14(8):2087-94. PubMed ID: 15987898
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of the beta-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12.
Tsay JT; Oh W; Larson TJ; Jackowski S; Rock CO
J Biol Chem; 1992 Apr; 267(10):6807-14. PubMed ID: 1551888
[TBL] [Abstract][Full Text] [Related]
11. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial FabH Inhibitors with Mode of Action Validated in Haemophilus influenzae by in Vitro Resistance Mutation Mapping.
McKinney DC; Eyermann CJ; Gu RF; Hu J; Kazmirski SL; Lahiri SD; McKenzie AR; Shapiro AB; Breault G
ACS Infect Dis; 2016 Jul; 2(7):456-64. PubMed ID: 27626097
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
[TBL] [Abstract][Full Text] [Related]
14. Beta-ketoacyl-acyl carrier protein synthase III from pea (Pisum sativum L.): properties, inhibition by a novel thiolactomycin analogue and isolation of a cDNA clone encoding the enzyme.
Jones AL; Gane AM; Herbert D; Willey DL; Rutter AJ; Kille P; Dancer JE; Harwood JL
Planta; 2003 Mar; 216(5):752-61. PubMed ID: 12624762
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the fatty acid profile of Streptomyces coelicolor by replacement of the initiation enzyme 3-ketoacyl acyl carrier protein synthase III (FabH).
Li Y; Florova G; Reynolds KA
J Bacteriol; 2005 Jun; 187(11):3795-9. PubMed ID: 15901703
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A.
Musayev F; Sachdeva S; Scarsdale JN; Reynolds KA; Wright HT
J Mol Biol; 2005 Mar; 346(5):1313-21. PubMed ID: 15713483
[TBL] [Abstract][Full Text] [Related]
17. Bacterial β-ketoacyl-acyl carrier protein synthase III (FabH) as a target for novel antibacterial agents design.
Lu XY; Tang J; Zhang Z; Ding K
Curr Med Chem; 2015; 22(5):651-67. PubMed ID: 25515508
[TBL] [Abstract][Full Text] [Related]
18. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking.
Fernandes TB; Segretti ND; Lourenço FR; Cândido TM; Baby AR; Barbosa EG; Parise-Filho R
Med Chem; 2021; 17(5):474-484. PubMed ID: 31763975
[TBL] [Abstract][Full Text] [Related]
19. Probing the mechanism of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis and substrate specificity.
Brown AK; Sridharan S; Kremer L; Lindenberg S; Dover LG; Sacchettini JC; Besra GS
J Biol Chem; 2005 Sep; 280(37):32539-47. PubMed ID: 16040614
[TBL] [Abstract][Full Text] [Related]
20. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
Shamim A; Abbasi SW; Azam SS
J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
